Quick Answer
Pulmonx Corp reported Diluted EPS of $1.33 per share (loss) for fiscal year 2025.
Pulmonx Corp Diluted EPS — Annual History
| Fiscal Year | Diluted EPS | YoY Change |
|---|---|---|
| 2025 | -$1.33 | +7.6% |
| 2024 | -$1.44 | +10.0% |
| 2023 | -$1.60 | -0.6% |
| 2022 | -$1.59 | -17.8% |
| 2021 | -$1.35 | +57.3% |
| 2020 | -$3.16 | — |
Quarterly Diluted EPS
| Quarter Ending | Diluted EPS | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$0.34 | +5.6% | +10.5% |
| June 30, 2025 | -$0.38 | +2.6% | -5.6% |
| March 31, 2025 | -$0.36 | +0.0% | +0.0% |
| September 30, 2024 | -$0.36 | +7.7% | +7.7% |
| June 30, 2024 | -$0.39 | +9.3% | -8.3% |
| March 31, 2024 | -$0.36 | +14.3% | +7.7% |
| September 30, 2023 | -$0.39 | -2.6% | +9.3% |
| June 30, 2023 | -$0.43 | -7.5% | -2.4% |
- Pulmonx Corp showed an increase of +7.6% in Diluted EPS compared to the prior fiscal year.
- Over the 2020–2025 period, Pulmonx Corp’s diluted eps has grown by 57.9% (from $3.16 per share (loss) to $1.33 per share (loss)).
- The most recent figure is from Pulmonx Corp’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 10, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: